These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Primary immunosuppression and outcome differences after heart transplantation: tacrolimus versus cyclosporine. Castel MA; Farrero M; Vallejos I; Cardona M; Regueiro A; Pérez-Villa F Transplant Proc; 2011; 43(6):2244-6. PubMed ID: 21839245 [TBL] [Abstract][Full Text] [Related]
6. A prospective randomized study comparing cyclosporine versus tacrolimus combined with daclizumab, mycophenolate mofetil, and steroids in heart transplantation. Sánchez-Lázaro IJ; Almenar L; Martínez-Dolz L; Buendía-Fuentes F; Agüero J; Navarro-Manchón J; Vicente JL; Salvador A Clin Transplant; 2011; 25(4):606-13. PubMed ID: 20682020 [TBL] [Abstract][Full Text] [Related]
7. Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial. Krämer BK; Klinger M; Vítko Š; Glyda M; Midtvedt K; Stefoni S; Citterio F; Pietruck F; Squifflet JP; Segoloni G; Krüger B; Sperschneider H; Banas B; Bäckman L; Weber M; Carmellini M; Perner F; Claesson K; Marcinkowski W; Ostrowski M; Senatorski G; Nordström J; Salmela K Transplantation; 2012 Sep; 94(5):492-8. PubMed ID: 22858806 [TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients. Silva HT; Yang HC; Meier-Kriesche HU; Croy R; Holman J; Fitzsimmons WE; First MR Transplantation; 2014 Mar; 97(6):636-41. PubMed ID: 24521771 [TBL] [Abstract][Full Text] [Related]
9. Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? Meiser BM; Groetzner J; Kaczmarek I; Landwehr P; Müller M; Jung S; Uberfuhr P; Fraunberger P; Stempfle HU; Weis M; Reichart B Transplantation; 2004 Aug; 78(4):591-8. PubMed ID: 15446320 [TBL] [Abstract][Full Text] [Related]
10. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960 [TBL] [Abstract][Full Text] [Related]
11. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910 [TBL] [Abstract][Full Text] [Related]
12. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols. Treede H; Klepetko W; Reichenspurner H; Zuckermann A; Meiser B; Birsan T; Wisser W; Reichert B; J Heart Lung Transplant; 2001 May; 20(5):511-7. PubMed ID: 11343977 [TBL] [Abstract][Full Text] [Related]
13. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. Ahsan N; Johnson C; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Salm K; Tolzman D; Fitzsimmons WE Transplantation; 2001 Jul; 72(2):245-50. PubMed ID: 11477347 [TBL] [Abstract][Full Text] [Related]
14. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up. Lee YJ; Kim B; Lee JE; Kim YG; Kim DJ; Kim SJ; Joh JW; Oh HY; Huh W Transpl Int; 2010 Feb; 23(2):147-54. PubMed ID: 19744223 [TBL] [Abstract][Full Text] [Related]
16. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids. Bunnapradist S; Daswani A; Takemoto SK Transplantation; 2003 Jul; 76(1):10-5. PubMed ID: 12865780 [TBL] [Abstract][Full Text] [Related]
17. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation. Langrehr JM; Klupp J; Glanemann M; Junge G; Pfitzmann R; Bahra M; Radtke C; Neumann U; Neuhaus R; Neuhaus P Clin Transplant; 2006; 20(3):272-83. PubMed ID: 16824141 [TBL] [Abstract][Full Text] [Related]
18. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation. Fisher RA; Stone JJ; Wolfe LG; Rodgers CM; Anderson ML; Sterling RK; Shiffman ML; Luketic VA; Contos MJ; Mills AS; Ferreira-Gonzalez A; Posner MP Clin Transplant; 2004 Aug; 18(4):463-72. PubMed ID: 15233827 [TBL] [Abstract][Full Text] [Related]